Abdominal vagal signalling: a novel role for cholecystokinin in circulatory control
Potassium homeostasis and management of dyskalemia in kidney diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
The eligibility criteria are more specific than early coverage suggested
The safety and efficacy of Semaglutide GLP-1 have been evaluated in clinical trials for up to two years, and ongoing studies continue to assess its long-term effects
With FDA approval, resmetirom, a liver-targeted thyroid hormone receptor- (THR) selective agonist, changes the MASH drug development landscape
For tumour xenograft experiments, athymic nude NU/J mice (The Jackson Laboratory, 002019) were used (female, at least 8 weeks old)